These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3005680)

  • 1. Leads from the MMWR. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    JAMA; 1986 Apr; 255(14):1843-4, 1849. PubMed ID: 3005680
    [No Abstract]   [Full Text] [Related]  

  • 2. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leads from the MMWR. Apparent transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus from child to mother providing health care.
    JAMA; 1986 Feb; 255(8):1005, 1009-10. PubMed ID: 3003413
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome.
    Blattner WA; Biggar RJ; Weiss SH; Melbye M; Goedert JJ
    Ann Intern Med; 1985 Nov; 103(5):665-70. PubMed ID: 2996397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Dec; 34(48):721-6, 731-2. PubMed ID: 2999576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status report on the acquired immunodeficiency syndrome. Human T-cell lymphotropic virus type III testing. Council on Scientific Affairs.
    JAMA; 1985 Sep; 254(10):1342-5. PubMed ID: 2991616
    [No Abstract]   [Full Text] [Related]  

  • 7. The epidemiology and prevention of the acquired immunodeficiency syndrome.
    Curran JW
    Ann Intern Med; 1985 Nov; 103(5):657-62. PubMed ID: 2996395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leads from the MMWR. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus.
    JAMA; 1986 Aug; 256(6):703-4. PubMed ID: 3014176
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jun; 35(23):376-8, 383. PubMed ID: 3012309
    [No Abstract]   [Full Text] [Related]  

  • 10. Leads from the MMWR. Recommendations for assisting in the prevention of perinatal transmission of HTLV-III/LAV and acquired immunodeficiency syndrome.
    JAMA; 1986 Jan; 255(1):25-7, 31. PubMed ID: 2999456
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Nov; 34(45):681-6, 691-5. PubMed ID: 2997587
    [No Abstract]   [Full Text] [Related]  

  • 12. The natural history of human T lymphotropic virus-III infection: the cause of AIDS.
    Melbye M
    Br Med J (Clin Res Ed); 1986 Jan; 292(6512):5-12. PubMed ID: 3002536
    [No Abstract]   [Full Text] [Related]  

  • 13. Leads from the MMWR. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody prevalence in US military recruit applicants.
    JAMA; 1986 Aug 22-29; 256(8):975-7. PubMed ID: 3016355
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS. Epidemiology update.
    Bennett JA
    Am J Nurs; 1985 Sep; 85(9):968-72. PubMed ID: 2994475
    [No Abstract]   [Full Text] [Related]  

  • 15. Leads from the MMWR. Heterosexual transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    JAMA; 1985 Oct; 254(15):2051-2. PubMed ID: 3840211
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Apr; 35(14):231-3. PubMed ID: 3007971
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward a national AIDS prevention strategy.
    Joseph SC
    Hosp Pract (Off Ed); 1987 Aug; 22(8):15-6. PubMed ID: 3040786
    [No Abstract]   [Full Text] [Related]  

  • 18. Leads from the MMWR. Summary: Recommendations for preventing transmission of infection with HTLV-III/LAV in the workplace.
    JAMA; 1985 Dec; 254(21):3023-6. PubMed ID: 2997494
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic generalized lymphadenopathy with splenomegaly associated with HTLV-III virus antibodies].
    Mijović A; Stevanović G; Brkić S; Dimitrijević M; Rolović Z; Ruvidić R
    Srp Arh Celok Lek; 1986 Jan; 114(1):109-20. PubMed ID: 3014667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.